Latest news and press releases about AirSculpt Technologies, Inc. (AIRS): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.
Price
| Price | $2.10 |
| Market Cap | $148M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.56 |
| EV / EBITDA | 72.80 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -12.52% |
| Return on Invested Capital | -5.46% |
| Return on Assets | -6.07% |
| Gross Margin | 57.63% |
| Operating Margin | -7.85% |
| Net Margin | -7.79% |
Related companies: AMN · AQST · CMPS · CYH · DRIO · INNV · MLTX
Explore sector: Healthcare · Medical - Care Facilities
More sections of AIRS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks